023 Risk Stratification Using CHA2DS2-VASc and CHADS2 Scores in Patients With Chronic Atherosclerotic Cardiovascular Disease Receiving Aspirin With or Without Rivaroxaban: An Analysis of the COMPASS Trial
Title:
023 Risk Stratification Using CHA2DS2-VASc and CHADS2 Scores in Patients With Chronic Atherosclerotic Cardiovascular Disease Receiving Aspirin With or Without Rivaroxaban: An Analysis of the COMPASS Trial
Author:
Sen, J. Tonkin, A. Varigos, J. Fonguh, S. Berkowitz, S. Yusuf, S. Verhamme, P. Vanassche, T. Anand, S. Fox, K. Eikelboom, J. Amerena, J.